Nucleic Acid Therapeutics
The CAS Research Focus brings together researchers to discuss the current state of development in the different research branches of nucleic acid-based therapeutics, as well as potential alternatives, and to explore new approaches.
The Corona pandemic has initiated a new phase in the field of vaccine development with the generation of RNA-based vaccines. But not only there: therapeutics developed on the basis of nucleic acids will play an increasingly important role in drug development or therapy in the coming years and change medicine. For untreatable or poorly treatable diseases, the new class of substances will show breakthrough treatment successes.
The CAS Research Focus brings together researchers to discuss the current state of development in the different research branches of nucleic acid-based therapeutics, as well as potential alternatives, and to explore new approaches.
Spokespersons
Events
-
23 JanDeveloping mRNA Based TherapeuticsReferent: Dr. Patrick Baumhof (CureVac, Tübingen) | Moderation: Prof. Dr. Olivia Merkel (LMU)
-
30 NovGene Silencing in HSPCs with an Apolipoprotein A1-Based Nanodelivery Platform
Speaker: Prof. Roy van der Meel, Ph.D. (Eindhoven University of Technology) | Chair: Dr. Sabine Schneider (LMU)
-
19 JulLiving in the World of RNA Therapeutics
Speaker: Dr. Muthiah Manoharan (Alnylam Pharmaceuticals) | Moderation: Prof. Dr. Olivia Merkel (LMU)
-
19 JanOn the Development of Personalized Cancer Vaccines Based on HLA Ligandome Analysis
Speaker: Prof. Dr. Hans-Georg Rammensee | Moderation: Prof. Dr. Sebastian Kobold (LMU)
Workshop "New RNA Therapeutics"
- Workshop led by Prof. Dr. Olivia Merkel (CAS Young Center/LMU) and Prof. Dr. Thomas Carell (LMU), 24 June 2022